SAREPTA THERAPEUTICS, INC.: 10-Q filed 2012-08-07
What SAREPTA THERAPEUTICS, INC. reported in its quarterly report filed 2012-08-07 (fiscal Q2 2012): 30 published measures, 95 facts as tagged in accession 0001193125-12-340912.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-08-07
- Fiscal period
- fiscal Q2 2012
- Accession
- 0001193125-12-340912 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SAREPTA THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 42,101,000 | USD | |
| At 2011-12-31 | 54,368,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 22,500,000 | USD | |
| At 2011-12-31 | 31,017,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 24,491,000 | USD | |
| At 2011-12-31 | 39,904,000 | USD | |
| At 2011-06-30 | 54,188,000 | USD | |
| At 2010-12-31 | 33,589,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 8,038,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -9,666,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | -319,630,000 | USD | 11667 |
| 2011-04-01 to 2011-06-30 | 1,279,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 3,112,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -14,731,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | -244,945,000 | USD | 11667 |
| 2011-01-01 to 2011-06-30 | -10,508,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 143,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | 20,022,000 | USD | 11667 |
| 2011-01-01 to 2011-06-30 | 676,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -41,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | 297,106,000 | USD | 11667 |
| 2011-01-01 to 2011-06-30 | 32,308,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -641,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | -27,670,000 | USD | 11667 |
| 2011-01-01 to 2011-06-30 | -1,201,000 | USD | 181 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 22,624,000 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 22,624,000 | shares | 182 |
| 2011-04-01 to 2011-06-30 | 22,348,000 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 20,558,000 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 22,658,000 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 22,624,000 | shares | 182 |
| 2011-04-01 to 2011-06-30 | 23,153,000 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 21,670,000 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0.36 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | -0.43 | USD/shares | 182 |
| 2011-04-01 to 2011-06-30 | 0.06 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | 0.15 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0.35 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | -0.43 | USD/shares | 182 |
| 2011-04-01 to 2011-06-30 | 0.06 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | 0.14 | USD/shares | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 3,898,000 | USD | |
| At 2011-12-31 | 4,265,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 1,148,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | 30,143,000 | USD | 11667 |
| 2011-01-01 to 2011-06-30 | 1,862,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -5,557,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -12,431,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | -343,396,000 | USD | 11667 |
| 2011-04-01 to 2011-06-30 | -10,125,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -15,656,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 33,232,000 | USD | |
| At 2011-12-31 | 45,184,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 17,131,000 | USD | |
| At 2011-12-31 | 20,601,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 8,813,000 | USD | |
| At 2011-12-31 | 9,396,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 4,740,000 | USD | |
| At 2011-12-31 | 4,764,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 7,180,000 | USD | |
| At 2011-12-31 | 3,633,000 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
| 1980-07-22 to 2012-06-30 | 289,000 | USD | 11667 |
| 2011-01-01 to 2011-06-30 | 0 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 13,849,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 28,654,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | 361,920,000 | USD | 11667 |
| 2011-04-01 to 2011-06-30 | 17,750,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 32,551,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 22,623,965 | shares | |
| At 2011-12-31 | 22,623,853 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 342,128,000 | USD | |
| At 2011-12-31 | 340,979,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 16,208,000 | USD | |
| At 2011-12-31 | 15,765,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 231,000 | USD | |
| At 2011-12-31 | 155,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 8,038,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -9,666,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | -319,630,000 | USD | 11667 |
| 2011-04-01 to 2011-06-30 | 1,279,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 3,112,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 2,915,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 6,196,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | 110,653,000 | USD | 11667 |
| 2011-04-01 to 2011-06-30 | 3,960,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 8,986,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 715,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | 21,160,000 | USD | 11667 |
| 2011-01-01 to 2011-06-30 | 490,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 13,595,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,765,000 | USD | 182 |
| 1980-07-22 to 2012-06-30 | 23,766,000 | USD | 11667 |
| 2011-04-01 to 2011-06-30 | 11,404,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 18,768,000 | USD | 181 |
Inspect the source
- Entity
- SAREPTA THERAPEUTICS, INC. / CIK 0000873303
- Captured
- 2026-09-20T05:00:35.473Z
- SEC response SHA-256
73fbffcbdadfe28b857d7fca50ab4aac61e15003102807aade5f366cc35bb6b9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000873303.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))